TABLE 2.
Prechip Quality |
Postchip Quality |
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
VCU |
NCI |
VCU |
NCI |
|||||||||
A260:A280 | 28S:18S | RIN | A260:A280 | 28S:18S | RIN | % Present |
3′:5′ Ratio, GAPDH |
3′:5′ Ratio, β-actin |
% Present |
3′:5′ Ratio, GAPDH |
3′:5′ Ratio, β-actin |
|
1 | 2.03 | 1.9 | 9.1 | 2.09 | 1.6 | 9.1 | 48.8 | 1.69 | 3.16 | 55.1 | 1.29 | 1.95 |
2 | 2 | 1.6 | 9.8 | 1.9 | 1.3 | 9.8 | 43.4 | 1.48 | 2.90 | 40.3 | 6.03 | 34.04 |
3 | 1.89 | 1.7 | 8.9 | 2.07 | 1.3 | 8.9 | 51.5 | 1.34 | 3.74 | 49.1 | 1.23 | 2.48 |
4 | 2.05 | 2 | 8.6 | 2.09 | 1.8 | 8.1 | 44.9 | 1.75 | 4.34 | 41.0 | 1.66 | 3.54 |
5 | 2.1 | 1.8 | 9.2 | 2.07 | 1.4 | 9.2 | 45.0 | 1.87 | 4.41 | 43.1 | 1.52 | 2.66 |
6 | 2.04 | 1.8 | 9.3 | 2.07 | 1.7 | 9.3 | 43.2 | 1.74 | 3.74 | 49.7 | 1.21 | 2.18 |
7 | 1.91 | 1.6 | 9.4 | 2.12 | 1.6 | 9.4 | 44.9 | 1.71 | 4.02 | 49.4 | 1.17 | 1.95 |
8 | 2.04 | 1.8 | 9.2 | 1.99 | 1.4 | 9.2 | 50.1 | 1.54 | 3.12 | 51.6 | 1.39 | 2.32 |
9 | 2 | 1.8 | 8.9 | 1.82 | 1.2 | 8.8 | 47.5 | 1.51 | 2.38 | 38.5 | 1.55 | 3.49 |
10 | 2.06 | 1.6 | 9.2 | 2.09 | 1.6 | 9.2 | 24.0 | 1.19 | 4.89 | 38.7 | 2.09 | 6.77 |
11 | 2 | 1.7 | 8.7 | 2.07 | 1.2 | 8.6 | 24.2 | 0.91 | 2.44 | 52.8 | 1.01 | 1.47 |
12 | 1.89 | 1.9 | 9.3 | 2.09 | 1.3 | 9.2 | 50.0 | 1.37 | 1.97 | 55.0 | 1.24 | 2.33 |
GAPDH indicates glyceraldehyde-3-phosphate dehydrogenase; IVT, in vitro transcription.